Dr. Dimanthi Pliatsika
Dr. Dimanthi Pliatsika
ZHAW
School of Life Sciences and Facility Management
Section for Organic and Medicinal Chemistry
Einsiedlerstrasse 31
8820 Wädenswil
Network
ORCID digital identifier
Projects
- Evaluation of the potential of targeting the IFN1 pathway / Deputy project leader / laufend
- Evaluation of the potential of PROTACs / Deputy project leader / laufend
- Morbillivirus cell entry machinery: mechanisms, structures and antiviral drug discovery / Team member / laufend
- Platform for drug target identification / Deputy project leader / abgeschlossen
Publications
-
Pliatsika, Dimanthi; Blatter, Cindy; Riedl, Rainer,
2024.
Targeted protein degradation : current molecular targets, localization, and strategies.
Drug Discovery Today.
29(11), pp. 104178.
Available from: https://doi.org/10.1016/j.drudis.2024.104178
-
Kalbermatter, David; Jeckelmann, Jean-Marc; Wyss, Marianne; Shrestha, Neeta; Pliatsika, Dimanthi; Riedl, Rainer; Lemmin, Thomas; Plattet, Philippe; Fotiadis, Dimitrios,
2023.
Structure and supramolecular organization of the canine distemper virus attachment glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America.
120(6), pp. e2208866120.
Available from: https://doi.org/10.1073/pnas.2208866120
-
Zizzari, Alessandra Tania; Pliatsika, Dimanthi; Gall, Flavio; Fischer, Thomas; Riedl, Rainer,
2021.
New perspectives in oral peptide delivery.
Drug Discovery Today.
26(4), pp. 1097-1105.
Available from: https://doi.org/10.1016/j.drudis.2021.01.020
-
Rimle, Lukas; Pliatsika, Dimanthi; Arnold, Noëlle; Kurth, Sandra; Kaiser, Marcel; Mäser, Pascal; Kemmler, Michael; Adams, Michael; Riedl, Rainer; von Ballmoos, Christoph,
2024.
Molecular basis for leucinostatin A toxicity in mammals.
In:
22nd European Bioenergetics Conference (EBEC), Innsbruck, Austria, 26-31 August 2024.
Elsevier.
Available from: https://doi.org/10.1016/j.bbabio.2024.149316
Patents and patent applications
-
Adams, Michael; Kemmler, Michael; Pliatsika, Dimanthi; Riedl, Rainer,
2024.
Topical treatment of skin cancer using oligopeptides.
Patent number WO2024033418 A1
(2024-02-15)
.
Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2024033418A1
-
Adams, Michael; Kemmler, Michael; Riedl, Rainer; Pliatsika, Dimanthi; Imanidis, Georgios; Herzig, Susanne; Kaiser, Marcel; Mäser, Pascal,
2022.
Patent number WO2022167656 A1
(2022-08-11)
.
Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2022167656A1